Nizar J. Bahlis, MD, discusses updated data from the phase 3 MAIA trial in multiple myeloma.
Nizar J. Bahlis, MD
Advertisement
Articles by Nizar J. Bahlis, MD
Nizar J. Bahlis, MD, discusses updated data from the phase 3 MAIA trial in multiple myeloma.
Nizar J. Bahlis, MD, discusses daratumumab (Darzalex) plus lenalidomide (Revlimid) and dexamethasone in newly diagnosed multiple myeloma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Dr Pant on the Potential Significance of Daraxonrasib for PDAC Management
2
Teclistamab Plus Talquetamab Yields Significant Survival Benefits in Earlier-Line R/R Myeloma
3
European Commission Approves Camizestrant Plus CDK4/6 Inhibition for Emergent ESR1-Mutated Advanced Breast Cancer
4
FDA Accepts NDA for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer
5